Pembrolizumab with chemoradiation therapy vs placebo plus CRT for locally advanced head and neck squamous cell carcinoma

Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy

Pembro + CRT in HNSCC fails to deliver statistically significant event-free survival improvement

New era of early cancer detection blood tests on the horizon

Hyperthermic intraperitoneal chemo for locally advanced colon cancer

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan

Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy

Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19

Olaparib continues to show positive results in advanced ovarian cancer - 7 year data

How air pollution may trigger lung cancer in never-smokers

Nirogacestat success for desmoid tumours

Cervical cancer programme in Kenya: lessons to guide elimination as a public health problem